Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732300 | SCV000860233 | uncertain significance | not provided | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001047238 | SCV001211178 | uncertain significance | Atrial fibrillation, familial, 7 | 2023-11-23 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 287 of the KCNA5 protein (p.Ala287Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with KCNA5-related conditions. ClinVar contains an entry for this variant (Variation ID: 596455). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000732300 | SCV002562647 | likely benign | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Fulgent Genetics, |
RCV001047238 | SCV002784077 | uncertain significance | Atrial fibrillation, familial, 7 | 2021-08-30 | criteria provided, single submitter | clinical testing | |
John Welsh Cardiovascular Diagnostic Laboratory, |
RCV002285171 | SCV002575036 | uncertain significance | Pulmonary arterial hypertension | 2022-09-26 | no assertion criteria provided | clinical testing |